RG

Redmile Group Portfolio holdings

AUM $1.36B
1-Year Est. Return 111.01%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+111.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.7B
AUM Growth
+$43.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
67
New
Increased
Reduced
Closed

Top Buys

1
+$14.3M
2
+$14.2M
3
+$3.94M
4
ATXS
Astria Therapeutics
ATXS
+$3.46M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$3.13M

Top Sells

1
+$40.7M
2
+$25.6M
3
+$10.2M
4
KYMR icon
Kymera Therapeutics
KYMR
+$8.21M
5
TRDA icon
Entrada Therapeutics
TRDA
+$7.99M

Sector Composition

1 Healthcare 97.73%
2 Industrials 2.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$3.44M 0.2%
2,074,372
52
$3.42M 0.2%
+310,884
53
$3.13M 0.18%
3,065,714
54
$2.98M 0.18%
1,046,587
55
$2.85M 0.17%
4,920,178
-187,554
56
$2.69M 0.16%
+13,847
57
$2.09M 0.12%
442,826
58
$2.01M 0.12%
3,077,828
59
$1.64M 0.1%
1,608,089
60
$1.54M 0.09%
82,955
61
$1.01M 0.06%
63,067
-4,018
62
$680K 0.04%
715,607
63
$457K 0.03%
106,376
-1
64
– –
-411,631
65
– –
-94,405
66
– –
-154,509
67
– –
-560,971
1 2
3